Skip to main content
. 2019 Dec 30;3(1):22–50. doi: 10.5414/ALX02120E

Table 1. Next-generation ARIA-GRADE guidelines.

GRADE recommendation mHealth RWE Chamber studies
Oral H1-antihistamines are less potent than INCSs BUT many patients prefer oral drugs [5] No information on the patient’s preference [41, 59] No information on the patient’s preference
Intranasal H1-antihistamines are less effective than INCSs [5] [41, 59]
Intranasal H1-antihistamines are effective within minutes [5] [51, 54]
INCSs are potent medications [4, 5] [41, 59]
The onset of action of INCSs takes a few hours to a few days (except for ciclesonide that is effective quicker) [5] [53, 70]
The combination of INCSs and oral H1-antihistamines offers no advantage over INCSs [3, 4] [41, 59]
The fixed combination of INCSs and intranasal H1-antihistamines is more potent than INCSs YES – in case of moderate to severe symptoms [4] [41, 59]
The fixed combination of INCSs and intranasal H1-antihistamines is effective within minutes [16, 53, 55]
Leukotriene antagonists are less potent than INCSs [4, 5]

ARIA = Allergic Rhinitis and its Impact on Asthma; GRADE = Grading of Recommendations -Assessment, Development and Evaluation. (Reprinted with kind permission from [27, 32, 84]).